Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,4',5,7-tetrahydroxy-3'-methoxy-flavone
2. 3,4',5,7-tetrahydroxy-3'-methoxyflavone
3. 3-methyl-quercetin
4. 3-methylquercetin
5. 3-o-methylquercetin
6. Iso-rhamnetin
7. Isorhamnetine
1. 480-19-3
2. 3-methylquercetin
3. Isorhamnetol
4. Quercetin 3'-methyl Ether
5. 3'-methoxyquercetin
6. 3'-o-methylquercetin
7. 3'-methoxy-3,4',5,7-tetrahydroxyflavone
8. 3'-methylquercetin
9. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-chromen-4-one
10. C.i. 75680
11. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
12. 3,4',5,7-tetrahydroxy-3'-methoxyflavone
13. 3-methylquercetine
14. Flavone, 3'-methoxy-3,4',5,7-tetrahydroxy-
15. 4h-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-
16. Flavone, 3,4',5,7-tetrahydroxy-3'-methoxy-
17. 3,5,7,4'-tetrahydroxy-3'-methoxyflavone
18. 07x3ib4r4z
19. Chebi:6052
20. Chembl379064
21. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone
22. 4h-1-benzopyran-4-one, 2-(3-methoxy-4-hydroxyphenyl)-3,5,7-trihydroxy-
23. Mfcd00017310
24. Isorhamnetine
25. 3,5,7-trihydroxy-2-(4-hydroxy-3-metoxyphenyl)benzopyran-4-one
26. Ccris 3791
27. 3'-o-methyl Quercetin
28. Sr-05000002256
29. Einecs 207-545-5
30. Brn 0044723
31. Unii-07x3ib4r4z
32. Isorhanetin,(s)
33. Irh
34. 3,4',5,7-tetrahydroxy-3'-methoxy-flavone
35. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-1-benzopyran-4-one
36. Quercetin-3'-methyl Ether
37. Isorhamnetin [inci]
38. Oprea1_145406
39. Schembl19235
40. Isorhamnetin [usp-rs]
41. Megxp0_001863
42. Methylquercetin, 3'-o-
43. Acon1_000275
44. Bdbm23409
45. Isorhamnetin, Analytical Standard
46. Dtxsid10197379
47. Zinc517261
48. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromen-4-one
49. Bcp11534
50. Ex-a6804
51. Hy-n0776
52. Isorhamnetin, >=95.0% (hplc)
53. Lmpk12110002
54. S9111
55. Akos015905141
56. Ccg-208422
57. Ccg-208453
58. Cs-5945
59. Ncgc00163572-01
60. Ncgc00163572-02
61. Ncgc00163572-03
62. Ncgc00180719-01
63. Ac-20263
64. As-71136
65. Db-051498
66. Ft-0603409
67. I1068
68. N1358
69. 3'-methoxy-4',5,7-trihydroxyflavonol
70. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)
71. 480i193
72. Isorhamnetin (constituent Of Ginkgo) [dsc]
73. Q416138
74. Q-100518
75. Sr-05000002256-2
76. Sr-05000002256-3
77. Brd-k83977206-001-01-4
78. Isorhamnetin, Primary Pharmaceutical Reference Standard
79. Isorhamnetin, United States Pharmacopeia (usp) Reference Standard
80. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-benzopyran-4-one
81. 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4h-chromen-4-one #
| Molecular Weight | 316.26 g/mol |
|---|---|
| Molecular Formula | C16H12O7 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 316.05830272 g/mol |
| Monoisotopic Mass | 316.05830272 g/mol |
| Topological Polar Surface Area | 116 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 503 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Isorhamnetin has known human metabolites that include (2S,3S,4S,5R)-6-[5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Isorhamnetin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isorhamnetin, including repackagers and relabelers. The FDA regulates Isorhamnetin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isorhamnetin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Isorhamnetin supplier is an individual or a company that provides Isorhamnetin active pharmaceutical ingredient (API) or Isorhamnetin finished formulations upon request. The Isorhamnetin suppliers may include Isorhamnetin API manufacturers, exporters, distributors and traders.
Isorhamnetin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isorhamnetin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isorhamnetin GMP manufacturer or Isorhamnetin GMP API supplier for your needs.
A Isorhamnetin CoA (Certificate of Analysis) is a formal document that attests to Isorhamnetin's compliance with Isorhamnetin specifications and serves as a tool for batch-level quality control.
Isorhamnetin CoA mostly includes findings from lab analyses of a specific batch. For each Isorhamnetin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isorhamnetin may be tested according to a variety of international standards, such as European Pharmacopoeia (Isorhamnetin EP), Isorhamnetin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isorhamnetin USP).
LOOKING FOR A SUPPLIER?
